Fusion Antibodies Email Format
Biotechnology ResearchNorthern Ireland, United Kingdom11-50 Employees
Fusion Antibodies is a biotechnology research company focused on the discovery, engineering, and supply of antibody-related services for early-stage development. Its work centers on helping clients advance therapeutic antibodies through preclinical stages, with a track record of guiding hundreds of projects and several moving into clinical development. The company emphasizes precision early-stage discovery and employs proprietary platforms for antibody humanization, affinity maturation, and developability optimization to support clients’ research programs and reduce development risk. Based in Belfast, Northern Ireland, Fusion Antibodies operates in the biotechnology research sector and serves customers seeking to accelerate the design and optimization of antibody candidates. The firm has been active since 2001 and maintains a presence as a contract research entity providing discovery, design, and optimisation services for therapeutic antibodies and related applications. A recent development noted in public updates includes collaboration and project progress with external partners and initiatives in antibody targeting and validation programs.